Goodwin Procter advised Sichuan Kelun-Biotech Biopharmaceutical Co. on the deal.Sichuan Kelun-Biotech Biopharmaceutical Co. announced its exclusive license and collaboration agreement with Merck for ex-China development rights…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
